Literature DB >> 30525932

Identifying Preanalytic and Postanalytic Laboratory Quality Gaps Using a Data Warehouse and Structured Multidisciplinary Process.

Marsha A Raebel1, LeeAnn M Quintana1, Emily B Schroeder1, Susan M Shetterly1, Lisa E Pieper1, Paul L Epner1, Laura K Bechtel1, David H Smith1, Andrew T Sterrett1, Joseph A Chorny1, Ira M Lubin1.   

Abstract

CONTEXT.—: The laboratory total testing process includes preanalytic, analytic, and postanalytic phases, but most laboratory quality improvement efforts address the analytic phase. Expanding quality improvement to preanalytic and postanalytic phases via use of medical data warehouses, repositories that include clinical, utilization, and administrative data, can improve patient care by ensuring appropriate test utilization. Cross-department, multidisciplinary collaboration to address gaps and improve patient and system outcomes is beneficial. OBJECTIVE.—: To demonstrate medical data warehouse utility for characterizing laboratory-associated quality gaps amenable to preanalytic or postanalytic interventions. DESIGN.—: A multidisciplinary team identified quality gaps. Medical data warehouse data were queried to characterize gaps. Organizational leaders were interviewed about quality improvement priorities. A decision aid with elements including national guidelines, local and national importance, and measurable outcomes was completed for each gap. RESULTS.—: Gaps identified included (1) test ordering; (2) diagnosis, detection, and documentation, and (3) high-risk medication monitoring. After examination of medical data warehouse data including enrollment, diagnoses, laboratory, pharmacy, and procedures for baseline performance, high-risk medication monitoring was selected, specifically alanine aminotransferase, aspartate aminotransferase, complete blood count, and creatinine testing among patients receiving disease-modifying antirheumatic drugs. The test utilization gap was in monitoring timeliness (eg, >60% of patients had a monitoring gap exceeding the guideline recommended frequency). Other contributors to selecting this gap were organizational enthusiasm, regulatory labeling, and feasibility of a significant laboratory role in addressing the gap. CONCLUSIONS.—: A multidisciplinary process facilitated identification and selection of a laboratory medicine quality gap. Medical data warehouse data were instrumental in characterizing gaps.

Entities:  

Mesh:

Year:  2018        PMID: 30525932      PMCID: PMC6941735          DOI: 10.5858/arpa.2018-0093-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  33 in total

1.  Design considerations, architecture, and use of the Mini-Sentinel distributed data system.

Authors:  Lesley H Curtis; Mark G Weiner; Denise M Boudreau; William O Cooper; Gregory W Daniel; Vinit P Nair; Marsha A Raebel; Nicolas U Beaulieu; Robert Rosofsky; Tiffany S Woodworth; Jeffrey S Brown
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

2.  Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk.

Authors:  James H Flory; Jason Roy; Joshua J Gagne; Kevin Haynes; Lisa Herrinton; Christine Lu; Elisabetta Patorno; Azadeh Shoaibi; Marsha A Raebel
Journal:  J Comp Eff Res       Date:  2016-12-09       Impact factor: 1.744

3.  Issues and initiatives in the testing process in primary care physician offices.

Authors:  John M Hickner; Douglas H Fernald; Daniel M Harris; Eric G Poon; Nancy C Elder; James W Mold
Journal:  Jt Comm J Qual Patient Saf       Date:  2005-02

4.  Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel.

Authors:  Marsha A Raebel; Kevin Haynes; Tiffany S Woodworth; Gwyn Saylor; Elizabeth Cavagnaro; Kara O Coughlin; Lesley H Curtis; Mark G Weiner; Patrick Archdeacon; Jeffrey S Brown
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-02-18       Impact factor: 2.890

5.  An assessment of overutilization and underutilization of laboratory tests by expert physicians in the evaluation of patients for bleeding and thrombotic disorders in clinical context and in real time.

Authors:  Mayukh K Sarkar; Chad M Botz; Michael Laposata
Journal:  Diagnosis (Berl)       Date:  2017-03-01

Review 6.  Methotrexate for treating rheumatoid arthritis.

Authors:  Maria Angeles Lopez-Olivo; Harish R Siddhanamatha; Beverley Shea; Peter Tugwell; George A Wells; Maria E Suarez-Almazor
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10

Review 7.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-11-06       Impact factor: 4.794

9.  Exploring the iceberg of errors in laboratory medicine.

Authors:  Mario Plebani
Journal:  Clin Chim Acta       Date:  2009-03-18       Impact factor: 3.786

10.  The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration.

Authors:  Tyler R Ross; Daniel Ng; Jeffrey S Brown; Roy Pardee; Mark C Hornbrook; Gene Hart; John F Steiner
Journal:  EGEMS (Wash DC)       Date:  2014-03-24
View more
  2 in total

1.  Technology-Enabled Outreach to Patients Taking High-Risk Medications Reduces a Quality Gap in Completion of Clinical Laboratory Testing.

Authors:  Marsha A Raebel; Susan M Shetterly; Bharati Bhardwaja; Andrew T Sterrett; Emily B Schroeder; Joseph Chorny; Tyson P Hagen; David J Silverman; Rex Astles; Ira M Lubin
Journal:  Popul Health Manag       Date:  2019-05-20       Impact factor: 2.459

Review 2.  Use of the WISN method to assess the health workforce requirements for the high-volume clinical biochemical laboratories.

Authors:  Sanja Stankovic; Milena Santric Milicevic
Journal:  Hum Resour Health       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.